Mexoryl SX (Ecamsule) Market Size Worth $82.6 Million by 2031 | CAGR: 5.3%: AMR

Surge in awareness towards skincare and beauty among people, rise in concerns about skin protection against detrimental rays of the sun, increase in the standard of living of people, and extensive application for photo-protection purposes in all skin types are expected to drive the growth of the global mexoryl SX (ecamsule) market. Closed manufacturing facilities and reduced workforce during COVID-19 pandemic had a moderate impact on the growth of the market.


Portland, OR, Aug. 28, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global mexoryl SX (ecamsule) market generated $49.5 million in 2021, and is projected to reach $82.6 million by 2031, growing at a CAGR of 5.3% from 2022 to 2031. The report offers a detailed analysis of the top winning strategies, evolving market trends, market size and estimations, value chain, key investment pockets, drivers & opportunities, competitive landscape and regional landscape. The report is a useful source of information for new entrants, shareholders, frontrunners, and shareholders in introducing necessary strategies for the future and taking essential steps to significantly strengthen and heighten their position in the market.

Report Coverage & Details:

Report CoverageDetails
Forecast Period2022­–2031
Base Year2021
Market Size in 2021$49.5 million
Market Size in 2031$82.6 million
CAGR5.3%
No. of Pages in Report199
Segments CoveredPurity level, Application, and Region
Drivers Increase in the standard of living
Growth of the online retail platform
OpportunitiesSurge in awareness towards skincare and beauty among people
Rise in concerns about skin protection against sun rays
RestrainsLack of awareness among consumers
Limited to specific consumers


Download Sample PDF (199 Pages PDF with Insights): https://www.alliedmarketresearch.com/request-sample/17510

COVID-19 Scenario:

  • The outbreak of COVID-19 has had a moderate impact on the growth of the global mexoryl SX (ecamsule) market, owing to the occurrence of lockdowns in various countries across the globe.
  • Lockdowns resulted in the closure of various manufacturing facilities, including those of mexoryl SX (ecamsule), which adversely impacted its demand during the pandemic. Thus, there were disruptions in the supply chain for various personal hygiene and medical products.
  • This was mainly due to the stringent social distancing restrictions imposed by the government to significantly curb the spread of the virus during the pandemic.
  • Furthermore, due to these strict lockdown restrictions, more and more people were required to stay indoors to limit physical contact, which subsequently plummeted its demand during the pandemic.
  • However, gradual shifts of investment from other sectors to healthcare and skincare are expected to create ample opportunities for the market.

The report offers a detailed segmentation of the global mexoryl SX (ecamsule) market based on purity level, application, and region. The report provides a comprehensive analysis of every segment and their respective sub-segment with the help of graphical and tabular representation. This analysis can essentially help market players, investors, and new entrants in determining and devising strategies based on the fastest growing segments and highest revenue generation that is mentioned in the report.

Based on purity level, the more than 98% segment held the dominating market share in 2021, holding more than two-thirds of the global market, and is expected to maintain its leadership status during the forecast period. In addition, the same segment is expected to cite the fastest CAGR of 5.4% during the forecast period. The report also analyses other segments such as less than 98% segment.

Request the Covid19 Impact Analysis @ https://www.alliedmarketresearch.com/request-for-customization/17510?reqfor=covid

Based on application, the cosmetics segment held the largest market share in 2021, garnering nearly three-fourths of the global market, and is expected to maintain its leadership status during the forecast period. In addition, the same segment is expected to cite the fastest CAGR of 5.4% during the forecast period.

Based on region, the market across North America held the dominating market share in 2021, holding nearly one-third of the global market, and is expected to maintain its leadership status during the forecast period. The Europe region, on the other hand, is expected to cite the fastest CAGR of 5.8% during the forecast period.

The key players analyzed in the global mexoryl SX (ecamsule) market report include Biosynth Carbosynth, ChemScene LLC, Derma Company, National Analytical Corporation, Norna Technology Co., Skylead Pharmaceuticals & Chemicals, L'Oréal S.A., and MFCI CO., LTD (Hubei Meifeng Chemical Co., Ltd.).

The report analyzes these key players of the global mexoryl SX (ecamsule) market. These market players have made effective use of strategies such as joint ventures, collaborations, expansion, new product launches, partnerships, and others to maximize their foothold and prowess in the industry. The report is helpful in analyzing recent developments, product portfolio, business performance, and operating segments by prominent players in the market. 

Interested in Procuring this Report? Visit Here: https://www.alliedmarketresearch.com/mexoryl-sx-market/purchase-options

Avenue Basic Plan | Library Access | 1 Year Subscription |           

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenueTrial

Get more information: https://www.alliedmarketresearch.com/library-access

About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

 

Contact Data